Navigating the CMS 14-Day Rule in Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

October 16, 2015

Local Regional Therapy and Surgery for Melanoma

Dr. Sanjiv Agarwala discusses when and why to utilize local regional therapy versus surgery for melanoma.

April 14, 2015

Clinical Validation of CancerTYPE ID

Dr. Boccia compares CancerTYPE ID to other gene expression tests and reviews studies validating its accuracy and clinical utility.